The progression of inorganic nanoparticles and natural products for inflammatory bowel disease

被引:23
|
作者
Li, Qingrong [1 ]
Lin, Liting [2 ]
Zhang, Cong [3 ]
Zhang, Hengguo [4 ]
Ma, Yan [3 ]
Qian, Haisheng [3 ]
Chen, Xu-Lin [5 ]
Wang, Xianwen [3 ]
机构
[1] Anhui Med Univ, Sch Basic Med Sci, Dept Pharmacol, Hefei 230032, Peoples R China
[2] Anhui Med Univ, Anhui Prov Inst Translat Med, Res & Engn Ctr Biomed Mat, Sch Biomed Engn, Hefei 230032, Peoples R China
[3] Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Gastroenterol, Div Life Sci & Med, Hefei 230026, Anhui, Peoples R China
[4] Anhui Med Univ, Coll & Hosp Stomatol, Key Lab Oral Dis Res Anhui Prov, Hefei 230032, Peoples R China
[5] Anhui Med Univ, Affiliated Hosp 1, Dept Burns, Hefei 230022, Peoples R China
关键词
Inflammatory bowel disease; Inorganic nanoparticles; Natural product nanomaterials; ROS/RNS; M1; macrophages; TNBS-INDUCED COLITIS; NITRIC-OXIDE; ULCERATIVE-COLITIS; MACROPHAGE POLARIZATION; COLORECTAL-CANCER; SIGNALING PATHWAY; REACTIVE OXYGEN; SELENIUM; CURCUMIN; BAICALIN;
D O I
10.1186/s12951-023-02246-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
There is a growing body of evidence indicating a close association between inflammatory bowel disease (IBD) and disrupted intestinal homeostasis. Excessive production of reactive oxygen species (ROS) and reactive nitrogen species (RNS), along with an increase in M1 proinflammatory macrophage infiltration during the activation of intestinal inflammation, plays a pivotal role in disrupting intestinal homeostasis in IBD. The overabundance of ROS/RNS can cause intestinal tissue damage and the disruption of crucial gut proteins, which ultimately compromises the integrity of the intestinal barrier. The proliferation of M1 macrophages contributes to an exaggerated immune response, further compromising the intestinal immune barrier. Currently, intestinal nanomaterials have gained widespread attention in the context of IBD due to their notable characteristics, including the ability to specifically target regions of interest, clear excess ROS/RNS, and mimic biological enzymes. In this review, we initially elucidated the gut microenvironment in IBD. Subsequently, we delineate therapeutic strategies involving two distinct types of nanomedicine, namely inorganic nanoparticles and natural product nanomaterials. Finally, we present a comprehensive overview of the promising prospects associated with the application of nanomedicine in future clinical settings for the treatment of IBD (graphic abstract).Graphical AbstractDifferent classes of nanomedicine are used to treat IBD. This review primarily elucidates the current etiology of inflammatory bowel disease and explores two prominent nanomaterial-based therapeutic approaches. First, it aims to eliminate excessive reactive oxygen species and reactive nitrogen species. Second, they focus on modulating the polarization of inflammatory macrophages and reducing the proportion of pro-inflammatory macrophages. Additionally, this article delves into the treatment of inflammatory bowel disease using inorganic metal nanomaterials and natural product nanomaterials
引用
收藏
页数:28
相关论文
共 50 条
  • [1] The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
    Qingrong Li
    Liting Lin
    Cong Zhang
    Hengguo Zhang
    Yan Ma
    Haisheng Qian
    Xu-Lin Chen
    Xianwen Wang
    Journal of Nanobiotechnology, 22
  • [2] The use of natural products in the treatment of inflammatory bowel disease
    Triantafillidis, J. K.
    ANNALS OF GASTROENTEROLOGY, 2008, 21 (01): : 14 - 16
  • [3] Review of natural products actions on cytokines in inflammatory bowel disease
    Hur, Sun Jin
    Kang, Sung Ho
    Jung, Ho Sung
    Kim, Sang Chul
    Jeon, Hyun Soo
    Kim, Ick Hee
    Lee, Jae Dong
    NUTRITION RESEARCH, 2012, 32 (11) : 801 - 816
  • [4] Natural Products on Inflammatory Bowel Disease: Role of Gut Microbes
    Cheng, Wen-Wen
    Liu, Bao-Hong
    Hou, Xiao-Ting
    Meng, Huan
    Wang, Dan
    Zhang, Cheng-Hao
    Yuan, Shuo
    Zhang, Qing-Gao
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2024, 52 (05): : 1275 - 1301
  • [5] Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?
    Vaghari-Tabari, Mostafa
    Alemi, Forough
    Zokaei, Maryam
    Moein, Soheila
    Qujeq, Durdi
    Yousefi, Bahman
    Farzami, Payam
    Hosseininasab, Seyed Soheil
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2024, 64 (13) : 4155 - 4178
  • [6] Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy
    Cao, Fan
    Liu, Jie
    Sha, Bing-Xian
    Pan, Hai-Feng
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (46) : 4893 - 4913
  • [7] Natural Products as a Source of Anti-Inflammatory Agents Associated with Inflammatory Bowel Disease
    Debnath, Trishna
    Kim, Da Hye
    Lim, Beong Ou
    MOLECULES, 2013, 18 (06) : 7253 - 7270
  • [8] Progression of inflammatory bowel disease in China
    Wang, Yu Fang
    Ouyang, Qin
    Hu, Ren Wei
    JOURNAL OF DIGESTIVE DISEASES, 2010, 11 (02) : 76 - 82
  • [9] Natural progression of childhood onset inflammatory bowel disease - A systematic review.
    Abraham, B.
    Mehta, S.
    El-Serag, H.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S40 - S40
  • [10] Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease
    Yuan, Shuo
    Li, You
    Li, Jiao
    Xue, Jia-Chen
    Wang, Qi
    Hou, Xiao-Ting
    Meng, Huan
    Nan, Ji-Xing
    Zhang, Qing-Gao
    FRONTIERS IN PHARMACOLOGY, 2022, 13